Frank Henrichmann on trust in AI for computerized system validation

Frank Henrichmann, Senior Executive Consultant at QFINITY, spoke with Life Science Connect about the use of AI in computerized system validation. The interview appeared on September 4, 2026, published simultaneously on Pharmaceutical Online, Bioprocess Online and Biosimilar Development. In the…

Who Pushes Back When the System Speaks?

A follow-up to the 47th GAMP D-A-CH Forum, Berlin, 11 March 2026. At the 47th GAMP D-A-CH Forum in Berlin in March 2026, Daniel Köpke and Oliver Herrmann asked what Human Oversight means when systems become more intelligent, more complex…

Three Signals, One Line: AI in the GxP Environment from Barcelona and Boston to the EMA Workshop

Within seven months, three signals converged on how to assess AI in the GxP environment: the rapporteur of the EMA drafting group for EU GMP Annex 22 explained the draft’s criticality logic in Barcelona in December 2025, a National Expert…

The PIC/S Recommendation PI 006, Fourth Version: The Paradigm Shift in Qualification and Validation

PIC/S has rewritten its recommendations on qualification and validation: PI 006-4 replaces the 2007 version on October 1, 2026. The real change sits beneath the chapters: validation is no longer a completed event but a continuously demonstrated state. That is precisely…

QFINITY at the ISPE AI Summit 2026: Advancing Practical AI Applications in GxP

The first ISPE AI in Life Sciences Summit – Powered by GAMP put one question at its centre, a question QFINITY has worked on for years: how do you move AI in GxP environments from experiment to validated, responsible use?…

QFINITY’s Senior Executive Consultant was interviewed by the Clinical Leader

The Clinical Leader interviewed Frank Henrichmann, Senior Executive Consultant at QFINITY and Co-Chair of the GAMP Global Steering Committee, on the occasion of the second edition of the ISPE GAMP Good Practice Guide for computerized GCP systems. The conversation explores…

QFINITY at the 5th Annual ACDM AI Symposium in London

On June 23 and 24, 2026, QFINITY participated in the 5th Annual ACDM AI Symposium in London – a gathering of experts from pharmaceutical companies, CROs, and technology providers on the growing role of artificial intelligence in clinical trials and…

5th Annual ACDM Symposium on AI in Clinical Trials | June 23-24, 2026

QFINITY will be attending the 5th ACDM Symposium on Artificial Intelligence in Clinical Trials (June 23-24, 2026, London) – represented by COO Marcus Schwabedissen, who will co-moderate the panel discussion “Turning AI into Impact: Real-World Applications in Clinical Data Management.”…

Oliver Herrmann Led the GAMP Track at the ISPE Europe Annual Conference 2026

At the ISPE Europe Annual Conference 2026 in Copenhagen (April 20-22), Oliver Herrmann, Founder and CEO of QFINITY, served as Track Lead for the GAMP track „Digital Compliance by Design: GAMP, AI, data integrity and digital validation in a digitalized…

Volunteer Profile on Frank Henrichmann published in pharmaceutical Engineering

Pharmaceutical Engineering, ISPE’s professional magazine, features Frank Henrichmann – Chair of the GAMP Global Steering Committee and Senior Executive Consultant at QFINITY – in its January/February 2026 issue, recognizing his long-standing volunteer engagement for GAMP guidelines and Good Practice Guides.…

Expert Article published in Pharmaceutical Engineering

Our expert article “How AI Will Transform Computerized System Validation” has been published in the latest issue of Pharmaceutical Engineering, the journal of the International Society for Pharmaceutical Engineering (ISPE). It also appears as a Feature Article on the ISPE…

Panel Discussion with QFINITY on the future of clinical computer systems

At Montrium’s Clinical QAI Day, Frank Henrichmann joined a key panel on the future of clinical computer systems – from rising quality and compliance demands to AI-enabled solutions that not only document processes but improve them. QFINITY took part in…